• BX Home
  • Pharmaceutical Approvals: Blog [Page 7]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

PHARMACEUTICAL APPROVALS

Pharmaceuticals approvals are the last step in a long process of government testing. This topic tracks the approval of prescription and over-the-counter pharmaceuticals.

Pharmaceutical Approvals is part of Business Exchange, suggested by Evan Rappaport. This topic contains 1,743 news and 329 blog items. Read updated news, blogs, and resources about Pharmaceutical Approvals. Find user-submitted articles and reactions on Pharmaceutical Approvals from like-minded professionals.

Blogs

Recent blog posts on this topic.

China's Home-Grown Insanity?more

Can this possibly be accurate? There are photos going around of what is purported to be the inside of the Harbin Sixth...

China's Home-Grown Insanity?more

Can this possibly be accurate? There are photos going around of what is purported to be the inside of the Harbin Sixth...

Chronic Fatigue: Enough Energy Left for Death Threats, Anywaymore

I've written a bit about the struggles to find the biological causes of chronic fatigue syndrome - but perhaps I should...

Chronic Fatigue: Enough Energy Left for Death Threats, Anywaymore

I've written a bit about the struggles to find the biological causes of chronic fatigue syndrome - but perhaps I should...

How Many New Drug Targets Aren't Even Real?more

So, are half the interesting new results in the medical/biology/med-chem literature impossible to reproduce? I linked...

How Many New Drug Targets Aren't Even Real?more

So, are half the interesting new results in the medical/biology/med-chem literature impossible to reproduce? I linked...

China's Pharma Ambitions: Hua Pharmaceuticals Respondsmore

I've had a detailed e-mail from John Choi, Chief Strategy and Business Office for Hua Medicine. That's the company that...

China's Pharma Ambitions: Hua Pharmaceuticals Respondsmore

I've had a detailed e-mail from John Choi, Chief Strategy and Business Office for Hua Medicine. That's the company that...

Day Off - Some Links and Some Ancient Greekmore

I'm adding a day to the weekend, so science is going to have to march on without me for a while. I do have a few...

The Ethics of Avastinmore

When we last spoke about the Avastin-and-breast-cancer story here, the FDA had rescinded its provisional approval for...

Fenofibrate: Good For Much?more

Abbott has some difficult times ahead with their fenofibrate franchise. That's TriCor, and its newer formulation,...

Quis Custodiet Ipso Custodes?more

Yesterday's look into the Google Ngram data set brought up a discussion in the comments on how good the numbers are in...

Phase II Failuresmore

We know what clinical trial success rates have been like for the last twenty years or so (hint: not so good).

Translation Neededmore

The "Opinionator" blog at the New York Times is trying here, but there's something not quite right.

Let the Healing Beginmore

This piece is too short to excerpt, so just Read The Whole Thing, as they say. The headline is "Pfizer Breaks...

A Look Inside the Compound Collectionsmore

Now here's a comparison that you don't get to see very often: how much do two large pharma compound collections...

Pfizer: Breaking Up Is Hard to Domore

Matthew Herper has a good piece over in Forbes on the speculation that Pfizer might devolve. Here's his breakdown of...

Selenium In a Drug Structure: Why Not?more

You don't see too many drugs with selenium in them, that's for sure. It's one of those elements that can be used to...

R&D Is For Losers?more

Now here's a piece that I'm looking for good reasons to dismiss. And I think its author, Jim Edwards, wouldn't mind...

Live Long and Prosper (and Be Bright Yellow at the Same Time)more

I'll freely admit to being very interested in research on aging and lifespan. It's a great subject from a scientific...

KV Pharmaceuticals and Makena: The FDA's Movemore

Most interesting - here's the FDA's latest statement on Makena, in response to KV Pharmaceuticals sending letters to...

Insider Trading at the FDAmore

Ah, insider trading. It's the province of Wall Street types in really expensive shirts, right? Like in the movies?...

The NIH Goes For the Gustomore

Here's an interesting funding opportunity from NIH: Recent advances in neuroscience offer unprecedented opportunities...

The Supreme Court Slams Big Pharma? Not Exactly.more

The Supreme Court came down with a decision the other day (Matrixx Initiatives v. Siracusano) that the headlines say...

More on KV and Makena's Pricingmore

I wanted to do some follow-up on the Makena story - the longtime progesterone ester drug that has now been newly...

Top Sources: Pharmaceutical Approvals

  • SeekingAlpha.com: Home Page
  • DODTracker.com New Deals Feed
  • stockerblog.blogspot.com
  • What's New at CBER
  • RSS from PharmiWeb.com
  • futurebiopharma.blogspot.com
  • In the Pipeline
  • FDA Law Blog
  • Health News from Medical News Today
  • Medical Device Recalls since November 11, 2009

Most Active Users in this Topic

see all contributors in Pharmaceutical Approvals

Featured White Papers

Post a Job

Jobs in this Topic

Drug Safety Physician Baxter International | Deerfield, IL
Posted: Apr 26
Reg Affairs Approval Associate/Sr. Associate Novartis Pharmaceuticals | East Hanover, NJ
Posted: Jun 12
QC Pharmaceutical Specialist II Role Genentech | South San Francisco, CA
Posted: Mar 30
Pharmaceutical Project Manager Cempra Pharmaceuticals | Chapel Hill, NC
Posted: Jun 11
Compliance Audit Manager (FDA – Healthcare Regulatory) Siemens | Iselin, NJ
Posted: Jun 19

Report comment contains invalid characters. ()
cancel
Search Cancel